Recurrent Depression, Resistant Clinician?

References

• Angst J, Baastrup P, Grof P, Hippius H, Poldinger W, Weis P. The course of monopolar depression and bipolar psychoses. Psychiatr Neurol Neurochir 1973; 76: 489–500
   PubMedGoogle Scholar
• Consensus Development Panel. NIMH/NIH Consensus Development Conference Statement: mood disorders: pharmacologic prevention of recurrences. Am J Psychiatry 1985; 142: 469–76
   PubMedGoogle Scholar
• Zis A P, Goodwin F K. Major affective disorder as a recurrent illness: a critical review. Arch Gen Psychiatry 1979; 36: 835–9
   PubMed Web of Science ®Google Scholar
• Kupfer D J. Long-term treatment of depression. J Clin Psychiatry 1991; 52(suppl 5)28–34
   PubMed Web of Science ®Google Scholar
• Fava G A. Holding on: depression, sensitization by antidepressant drugs, and the prodigal experts. Psychother Psychosom 1995; 64: 57–61
   Google Scholar
• Fava M, Kaji J. Continuation and maintenance treatments of major depressive disorder. Psychiatr Ann 1994; 24: 281–90
   Google Scholar
• Frank E, Prien R F, Jarrett R B, Keller M B, Kupfer D J, Lavori P W, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991; 48: 851–5
   PubMed Web of Science ®Google Scholar
• Kessler R C, McGonagle K A, Zhao S, Nelson C B, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8–19
   PubMed Web of Science ®Google Scholar
• Greenberg P E, Stiglin L E, Finkelstein S N, Berndt E R. The economic burden of depression in 1990. J Clin Psychiatry 1993; 54: 405–18
   PubMed Web of Science ®Google Scholar
• Wells K B, Stewart A, Hays R D, Burnam M A, Rogers W, Daniels M, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989; 262: 914–9
   PubMed Web of Science ®Google Scholar
• Keller M B. Depression: a long-term illness. Br J Psychiatry 1994; 165(suppl 26)9–15
   Google Scholar
• Angst J, Kupfer D J, Rosenbaum J F. Recovery from depression: risk or reality?. Acta Psychiatr Scand 1996; 93: 413–9
   Google Scholar
• Greden J F. Maintenance antidepressant treatment. Am Soc Clin Psychopharmacol Prog Notes 1995; 6: 28–34
   Google Scholar
• Greden J F. Antidepressant maintenance medications: when to discontinue and how to stop. J Clin Psychiatry 1993; 54(suppl8)39–45
   Google Scholar
• Keller M B, Shapiro R W, Lavori P W, Wolfe N. Relapse in major depressive disorder: analysis with the life table. Arch Gen Psychiatry 1982; 39: 911–5
   PubMed Web of Science ®Google Scholar
• Gonzales L R, Lewinsohn P M, Clarke G N. Longitudinal follow-up of unipolar depressives: an investigation of predictors of relapse. J Consult Clin Psychol 1985; 53: 461–9
   PubMed Web of Science ®Google Scholar
• Keller M B, Lavori P W, Lewis C E, Herman G L. Predictors of relapse in major depressive disorder. JAMA 1983; 250: 3299–304
   PubMed Web of Science ®Google Scholar
• Maj M, Veltro F, Pirozzi R, Lobrace S, Magliano L. Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. Am J Psychiatry 1992; 149: 795–800
   PubMed Web of Science ®Google Scholar
• Post R M. Mechanisms underlying the evolution of affective disorders: implications for long-term treatment. Severe depressive disorders, L Grunhaus, J F Greden. American Psychiatric Press, Washington, DC 1994; 23–65
   Google Scholar
• Prien R F, Kupfer D J. Continuation drug therapy for major depressive episodes: how long should it be maintained?. Am J Psychiatry 1986; 143: 18–23
   PubMed Web of Science ®Google Scholar
• Mueller T I, Leon A C, Keller M B, Solomon D A, Endicott J, Warshaw M. Ten-year cumulative probability of recurrence after recovery from an index episode of MDD. Presented at the 150th annual meeting of the American Psychiatric Association. San Diego, California 1997, May
   Google Scholar
• Endicott J, Spitzer R L, Fleiss J L, Cohen J. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33: 766–71
   PubMed Web of Science ®Google Scholar
• Keller M B, Lavori P W, Mueller T I, Endicott J, Coryell W, Hirschfeld R M, et al. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992; 49: 809–16
   PubMed Web of Science ®Google Scholar
• Keller M B, Lavori P W, Rice J, Coryell W, Hirschfeld R M. The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: a prospective follow-up. Am J Psychiatry 1986; 143: 24–8
   PubMed Web of Science ®Google Scholar
• Harrison W, Rabkin J, Stewart J W, McGrath P J, Tricamo E, Quitkin F. Phenelzine for chronic depression: a study of continuation treatment. J Clin Psychiatry 1986; 47: 346–9
   PubMed Web of Science ®Google Scholar
• Rosenbaum J F, Quitkin F M, Fava M, Amsterdam J, Fawcett J, Zajecka J, et al. Fluoxetine vs. placebo: long-term treatment of MDD. Presented at the 32nd annual meeting of the American College of Neuropsychopharmacology, Maui, Hawaii. 1993, December
   Google Scholar
• Doogan D P, Caillard V. Sertraline in the prevention of depression. Br J Psychiatry 1992; 160: 217–22
   PubMed Web of Science ®Google Scholar
• Montgomery S A, Dunbar G. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression. Int Clin Psychopharmacol 1993; 8: 189–95
   PubMed Web of Science ®Google Scholar
• Duboff E A. Long-term treatment of major depressive disorder with paroxetine. J Clin Psychopharmacol 1993; 13(suppl 2)28S–33S
   Google Scholar
• Anton S F, Robinson D S, Roberts D L, Kensler T T, English P A, Archibald D G. Long-term treatment of depression with nefazodone. Psychopharmacol Bull 1994; 30: 165–9
   Google Scholar
• Loonen A J, Peer P G, Zwanikken G J. Continuation and maintenance therapy with antidepressant agents: meta-analysis of research. Pharm Weekbl [Sci] 1991; 13: 167–75
   Google Scholar
• Peselow E D, Filippi A M, Goodnick P, Barouche F, Fieve R R. The short- and long-term efficacy of paroxetine HCI, B: Data from a double-blind crossover study and from a year-long term trial vs. imipramine and placebo. Psychopharmacol Bull 1989; 25: 272–6
   Google Scholar
• Montgomery S A, Dufour H, Brion S, Gailledreau J, Laqueille X, Ferrey G, et al. The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatry 1988; 153(suppl 3)69–76
   Google Scholar
• Robert P, Montgomery S A. Citalopram in doses of 20–60 mg is effective in depression relapse prevention: a placebo-controlled 6 month study. Int Clin Psychopharmacol 1995; 10(suppl 1)29–35
   PubMedGoogle Scholar
• Frank E, Kupfer D J, Perel J M, Corhes C, Jarrett D B, Mallinger A G, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990; 47: 1093–9
   PubMed Web of Science ®Google Scholar
• Kupfer D J, Frank E, Perel J M, Comes C, Mallinger A G, Thase M E, et al. Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1992; 49: 769–73
   PubMed Web of Science ®Google Scholar
• Fava M, Davidson K G. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996; 19: 179–200
   PubMed Web of Science ®Google Scholar
• Thase M E, Simons A D, McGeary J, Cahalane J F, Hughes C, Harden T, et al. Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. Am J Psychiatry 1992; 149: 1046–52
   PubMed Web of Science ®Google Scholar
• Thase M E, Simons A D. Cognitive behavior therapy and relapse of nonbipolar depression: parallels with pharmacotherapy. Psychopharmacol Bull 1992; 28: 117–22
   PubMed Web of Science ®Google Scholar
• Faravelli C, Ambonetti A, Pallanti S, Pazzagli A. Depressive relapses and incomplete recovery from index episode. Am J Psychiatry 1986; 143: 888–91
   PubMed Web of Science ®Google Scholar
• Simons A D, Murphy G E, Levine J L, Wetzel R D. Cognitive therapy and pharmacotherapy for depression: sustained improvement over one year. Arch Gen Psychiatry 1986; 43: 43–8
   PubMed Web of Science ®Google Scholar
• Mintz J, Mintz L I, Arruda M J, Hwang S S. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992; 49: 761–8
   PubMed Web of Science ®Google Scholar
• Fawcett J, Scheftner W A, Fogg L, Clarke D C, Young M A, Hedeker D, et al. Time-related predictors of suicide in major affective disorder. Am J Psychiatry 1990; 147: 1189–94
   PubMed Web of Science ®Google Scholar
• Frank E, Kupfer D J, Perel J M, Cornes C, Mallinger A G, Thase M E, et al. Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression. J Affect Disord 1993; 27: 139–45
   PubMed Web of Science ®Google Scholar
• Peselow E D, Difiglia C, Fieve R R. Relationship of dose to antidepressant prophylactic efficacy. Acta Psychiatr Scand 1991; 84: 571–4
   Google Scholar
• Kocsis J H, Friedman R A, Markowitz J C, Leon A C, Miller N L, Gniwesch L, et al. Maintenance therapy for chronic depression: a controlled clinical trial of desipramine. Arch Gen Psychiatry 1996; 53: 769–74
   PubMed Web of Science ®Google Scholar
• Klerman G L, Weissman M M, Rounsaville B J. Interpersonal psychotherapy of depression. Basic, New York 1984
   Google Scholar
• Robinson D S, Lerfald S C, Bennett B, Laux D, Devereaux E, Kayser A, et al. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study. Psychopharmacol Bull 1991; 27: 31–9
   PubMedGoogle Scholar
• Georgotas A, McCue R E, Cooper T B. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry 1989; 46: 783–6
   PubMed Web of Science ®Google Scholar
• Beck A T, Rush A J, Shaw B F, Emery G. Cognitive therapy of depression. Guilford, New York 1979
   Google Scholar
• Evans M D, Hollon S D, De Rubeis R J, Piasecki J M, Grove W M, Garvey M J, et al. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry 1992; 49: 802–8
   PubMed Web of Science ®Google Scholar
• Fava G A, Grandi S, Zielezny M, Canestrari R, Morphy M A. Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 1994; 151: 1295–9
   PubMed Web of Science ®Google Scholar
• Pava J A, Fava M, Levenson J A. Integrating cognitive therapy and pharmacotherapy in the treatment and prophylaxis of depression: a novel approach. Psychother Psychosom 1994; 61: 211–9
   PubMed Web of Science ®Google Scholar